Report : Europe Dermal Fillers Market Forecast to 2031 – Regional Analysis – by Product (Biodegradable and Nonbiodegradable), Material (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polmethylmethacrylate (PMMA), Fat Fillers, and Others), Application (Facial Line Correction Treatment, Lip Enhancement, Face Lift, Scar Treatment, and Others), and End User (Multispecialty Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, and Others)
At 9.1% CAGR, Europe Dermal Fillers Market is Speculated to be Worth US$ 2,243.45 Million by 2031, says Business Market Insights
According to Business Market Insights’ research, the Europe dermal fillers market was valued at US$ 1,120.76 million in 2023 and is expected to reach US$ 2,243.45 million by 2031, registering a CAGR of 9.1% from 2023 to 2031. Increasing preference for minimally invasive procedures and rising attraction of consumers toward beauty & wellness are among the critical factors attributed to drive the Europe dermal fillers market growth.
Minimally invasive procedures have gained popularity among consumers, as they offer several advantages over traditional surgical methods. These procedures involve less risk, minimal scarring, shorter recovery times, and often require only local anesthesia. Additionally, advancements in cosmetic techniques have made dermal fillers more effective and safer than ever before. Newer formulations of fillers are longer-lasting and provide more natural-looking results. This has increased consumer confidence in these procedures and contributed to their growing popularity. According to the global survey 2022 report by the International Society of Aesthetic Plastic Surgery (ISAPS), the total number of nonsurgical and surgical aesthetic procedures increased by 11.2% in 2022 compared to 2021, with more than 14.9 million surgical and 18.8 million nonsurgical procedures performed worldwide. Furthermore, age plays a substantial role in determining the unique needs of medical aesthetic procedures; adults are more inclined toward minimally invasive approaches. Furthermore, people aged 35–55 have a preference for minimally invasive cosmetic procedures over surgery. Plastic surgeons are increasingly interested in exploring them, and minimally invasive cosmetic and aesthetic procedures are now considered interdisciplinary. The advancement of nonsurgical technologies and new treatment alternatives has made aesthetics more accessible to a wider population. Patients in their 20s and 30s are driving this trend.
Overall, the benefits and accuracy offered by minimally invasive procedures over traditional surgery are expected to continue to drive the market growth during the forecast period. The ever-increasing interest in retaining a youthful appearance has facilitated various minimally invasive dermatological techniques. The field of cosmetic dermatology has been expanding globally. With the ever-increasing popularity of nonsurgical enhancement and an increasing number of patients who have been treated, the demand for fillers continues to rise, boosting the Europe dermal fillers market growth.
On the contrary, high cost of dermal filler procedures hamper the growth of Europe dermal fillers market.
Based on product, the Europe Dermal Fillers Market is bifurcated biodegradable and nonbiodegradable. The biodegradable segment held 90.9% market share in 2023, amassing US$ 1,019.13 million. It is projected to garner US$ 2,052.96 million by 2031 to register 9.1% CAGR during 2023–2031.
In terms of material, the Europe Dermal Fillers Market is categorized calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polmethylmethacrylate (PMMA), fat fillers, and others. The hyaluronic acid segment held 56.8% share of Europe dermal fillers market in 2023, amassing US$ 636.85 million. It is anticipated to garner US$ 1,319.72 million by 2031 to expand at 9.5% CAGR during 2023–2031.
By application, the Europe Dermal Fillers Market is segmented into facial line correction treatment, lip enhancement, face lift, scar treatment, and others. The lip enhancement segment held 35.5% market share in 2023, amassing US$ 397.51 million. It is projected to garner US$ 828.62 million by 2031 to register 9.6% CAGR during 2023–2031.
By end user, the Europe Dermal Fillers Market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. The dermatology clinics segment held 47.2% market share in 2023, amassing US$ 528.61 million. It is projected to garner US$ 1,087.55 million by 2031 to register 9.4% CAGR during 2023–2031.
By country, the Europe Dermal Fillers Market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 28.9% share of Europe dermal fillers market in 2023. It was assessed at US$ 324.35 million in 2023 and is likely to hit US$ 655.91 million by 2031, registering a CAGR of 9.2% during 2023–2031.
Key players operating in the Europe dermal fillers market are AbbVie Inc, BIOHA LABORATORIES, BIOXIS pharmaceuticals, Galderma SA, Merz Pharma GmbH & Co KGaA, Prollenium Medical Technologies, Sinclair Pharma Ltd, Suneva Medical, and TEOXANE LABORATORIES, among others.